Physician profile
Marcus Duane Stanbro
NPI 1811940224
$2,163.32
in general payments reported to CMS, 2019-2025
13 companies · $482 in 2025
The $482 reported for 2025 was more than what 76% of Phlebology providers received nationally (typical 2025 total: $141).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $632 · 2020: $86.29 · 2021: $180 · 2022: $231 · 2023: $458 · 2024: $93.95 · 2025: $482.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,034.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,034.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $516.49 | 2019-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Boston Scientific Corporation | $449.07 | 2019-2025 | Varithena Administration Pack |
| Janssen Pharmaceuticals, INC | $328.98 | 2019-2024 | Xarelto |
| Angiodynamics, INC. | $217.99 | 2023-2024 | Venacure 1470 Pro |
| Inari Medical, INC. | $170.35 | 2019 | |
| Biocompatibles, INC. | $154.59 | 2019 | |
| Pfizer INC. | $137.16 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $45.24 | 2023-2025 | Eliquis |
| Medtronic Vascular, INC. | $34.41 | 2020 | |
| Cashflow Solutions, LLC | $32.65 | 2023 | Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt |
| Medtronic, INC. | $32.15 | 2021 | |
| Koya Medical, INC. | $27.73 | 2025 | Koya Medical, Dayspring |
| Smith+Nephew, INC. | $16.51 | 2025 | Collagenase Santyl |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marcus Stanbro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.